Comparative Aphrodisiac Activity of Formulated Tablet of Bombax Ceiba Linn. Extract with Sildenafil Citrate Tablet in Male Mice
Abstract
The present work deals with pharmacological studies of formulated tablet of Bombax ceiba Linn root extract comparing with marketed one. An aphrodisiac activity by mating behavior test model was investigated. The dissolved tablet slurry (400 mg/kg body wt./day) was administered orally by gavages for 28 days. Mount latency (ML), intromission latency (IL), ejaculation latency (EL), mounting frequency (MF), intromission frequency (IF), ejaculation frequency (EF) and post-ejaculatory interval (PEI) are the parameters observed before and during the sexual behavior study at day 0, 7, 14, 21, and 28. The formulated tablet reduced significantly ML, IL, EL and PEI (p<0.05). The formulated tablet also increased significantly MF, IF and EF (p<0.05) as compared to the marketed formulation (Sildenafil Citrate-100 gm). These effects were observed in sexually active and inactive male mice. Bombax ceiba roots extract tablet (400 mg/kg body wt.) has comparative aphrodisiac activity with that of marketed formulation (Sildenafil citrate-100 mg) in inactive mice.
Keywords: Bombax ceiba, aphrodisiac, formulated tablet, sexual behavior study
Cite this Article
Pallavi D Rai, Sharada L Deore, Irfan A Farooqui et al. Comparative aphrodisiac activity of formulated tablet of bombax ceiba linn. extract with sildenafil citrate tablet in male mice. Research & Reviews: Journal of Pharmacology. 2015; 5(3): 19–26p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |